Merck Halts Trial of Once ‘promising’ Alzheimer’s Drug
US pharmaceutical giant Merck announced it is halting a clinical trial on a drug once touted as a promising treatment for Alzheimer’s disease, saying studies show it does not work. The decision was made to end trials on verubecestat for mild to moderate Alzheimer’s disease after an external study found there was “virtually no chance … Read more